2020 IPO

AbCellera Biologics Stock

Antibody therapeutics

Sign up today and learn more about AbCellera Biologics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About AbCellera Biologics Stock

AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.

Funding History

September 2013$0
August 2014$0
January 2017$0
April 2017$818K
September 2018$10.0M
March 2019$4.8M



Kevin Heyries

Co-Founder & Director

Véronique Lecault

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: